7069 CyberBuzz
- 1386
- +7+0.51%
CyberBuzz News
Volume change rate ranking (10:00) ~ Pixela, EXEDY, etc. are ranked
* In the volume change rate ranking, it is possible to know the interest of market participants, such as shopping trends, by comparing the average turnover for the last 5 days with the turnover on the day of distribution. ■Top Volume Change Rate [as of 5/28 10:32] (Last 5 Day Average Volume Comparison) Stock Code Stock Name Volume 5 Day Average Volume Volume Change Rate Stock Price Change Rate ＜6731＞ Pixela 15893900 491640 340.44% 0.282
CyberBuzz: Revised Quarterly Report - 19th Quarter 2nd Quarter (2024/01/01 - 2024/03/31)
The Tokyo Stock Exchange Growth Index continued to decline drastically, and the main stocks continued to weaken and hit year-to-date lows
TSE Growth Market Index 812.88 -11.82 /volume 115.04 million shares/trading price 126.7 billion yen TSE growth market 250 index 635.09 -8.43/turnover 91.19 million shares/trading price 112.2 billion yen Today's growth market continues to decline drastically in both the TSE Growth Market Index and the TSE Growth Market 250 Index. The number of rising stocks is 182, the number of falling stocks is 369, and 25 unchanged. The US stock market continued to rise on the 15th. The Dow Jones Industrial Average rose by $349.89 (+
Front market for high stop and low stop stocks
■Stop High＜1514＞Sumiseki Holdings＜1673＞WisdomTree Gin Exchange Traded Investment Trust ＜1730＞Aso Fromcleat ＜2813＞Kazuhiro Foods ＜6085＞Architects Studio Japan■Stop Yasu＜2708＞Kuze ＜2928＞RIZAP Group ＜4492＞Genetech ＜4598＞Delta-Fly PHARMA ＜6227＞AI Mecatec ＜7069＞Cyber Buzz ＜7687＞Miku Reed ＜9327＞e
CyberBuzz: Quarterly Report - 19th Quarter 2nd Quarter (2024/01/01 - 2024/03/31)
CyberBuzz: Confirmation Letter
Medrex, Blue Innovations, etc.
＜153A＞Kaulis Co., Ltd. Shimazu Atsuyoshi Stock Ownership Ratio 59.63% → 55.71% Reporting Obligation Date 2024/04/25 ＜3133＞Kaiho Co., Ltd. Yamada Toru Stock Ownership Ratio 12.99% → 14.18% Reporting Obligation Date 2024/04/26 ＜3976＞Shannon Co., Ltd. Wiz Partners Co., Ltd. Stock Ownership Ratio 57.31% → 58.54% Reporting Obligation Date 2024/05/0
Emerging market outlook: Pay attention to financial results announcements from leading companies, will momentum for growth market reviews increase soon
■Emerging markets rebounded from last week to this week (4/30 to 5/10), which will break 100 billion yen for 12 consecutive business days. The gain/fall rate against the 4/26 closing price was almost similar to the Nikkei Average of +0.78%, while the Growth Market Index was +0.80% and the Growth Market 250 Index was +0.87%. In addition to exchange rate fluctuations due to movements seen as yen buying/dollar sales intervention by the Japanese government, financial results announcements for Prime stocks took precedence, etc., the growth market
Brands that moved the day before part 2 Nippon Housing, Japanen, Sansei Technologies, etc.
<コード>Stock name 10-day closing price ⇒ compared to the previous day Alps Alpine ＜6770＞ 1506 -34.5 This fiscal year is expected to continue to decline in regular income. SANKYO ＜6417＞ 1535 -96 profit reduction guidance for the current fiscal year is viewed negatively. Chugoku Paint ＜4617＞ The forecast for a decline in ordinary profit for the current fiscal year 1919-139 is viewed negatively. Nippon Television HD ＜9404＞ 2116 -157.5 Both actual values and guidance are lower than expected. Corowide ＜7616＞ 1899.5 -166 a
The Tokyo Stock Exchange Growth Index continued to fall for 3 days, and there isn't even an index due to the position centered around stocks announcing financial results
TSE Growth Market Index 832.43 -3.56/ Volume 95.97 million shares/ trading price 94.8 billion yen TSE Growth Market 250 Index 650.23 -2.74 /turnover 74.22 million shares/ trading price 81.2 billion yen Today's growth market continued to decline for 3 days for both the TSE Growth Market Index and the TSE Growth Market 250 Index. The number of rising stocks is 205, the number of falling stocks is 331, and 36 unchanged. The US stock market rose on the 9th. The Dow Average was higher by $331.37 (+0.85%)
Front market [stocks that have moved, stocks that have been created]
*Infocom ＜4348＞ 3485 - It is reported that multiple factions are considering an acquisition. *Alps Logistics ＜9055＞ 5050 Ka - I'm close to the TOB price of Logistics. *Nissin ＜9066＞ 3795 - Due to announcements of drastic dividend increases and implementation of high-level stock buybacks. *Ceres ＜3696＞ 2191 +400 evaluates the high performance change rate for the first quarter. *Tsumura ＜4540＞ 4392 +700 will evaluate the forecast for a significant increase in profit for the current fiscal year. *Jigen ＜3679＞ 652
Brands that moved the day before part 1 Kawasaki Shigeru, GMOTECH, KOSÉ, etc.
<コード>Stock name closing price on the 9th ⇒ Kawasaki Shigeru ＜7012＞ 5607 +70024 business profit decreased by 43.9% compared to the previous day, but it exceeds previous expectations. The forecast for the fiscal year ending 25/3 is 2.8 times that of the previous fiscal year. Miyoshi Oil & Fat ＜4404＞ 1412+157 1st quarter operating profit was 1,233 billion yen. There was a shift from a deficit of 123 million yen in the same period last year to a surplus. Daicel ＜4202＞ announced changes to its 1558.5 +90 shareholder return policy and cancellation of company shares. Data HR ＜3628＞ 630 -10
The TSE Growth Index continues to decline slightly, and there is little sense of direction due to continued weak sales
TSE Growth Market Index 835.99 -3.01/volume 79.72 million shares/trading price 79.8 billion yen TSE growth market 250 index 652.97 -1.92/trading volume 62.39 million shares/trading price 71.3 billion yen Today's growth market continued to decline slightly in both the TSE Growth Market Index and the TSE Growth Market 250 Index. The number of rising stocks is 219, the number of falling stocks is 316, and 38 unchanged. The US stock market on the 8th was mixed. The Dow Jones Industrial Average rose by $172.13 (+0.44)
Emerging Market Stock Digest: Kudan continues to rise drastically for 3 days, data HR is at a year-to-date low
Year-to-date low. The operating profit and loss forecast for the fiscal year ending 24/6 has been revised downward from conventional profit and loss tons to a deficit of 900 million yen (deficit of 498 million yen in the previous fiscal year results). This is because the progress of orders for data health-related services etc. has been delayed, such as taking longer than expected, and sales are expected to fall below previous expectations.
Backstage [stocks that moved, stocks that were made]
*Kawasaki Shigeru ＜7012＞ 5607 +700Business profit for the fiscal year ending 24/3 decreased by 43.9%, but it exceeds previous forecasts. The forecast for the fiscal year ending 25/3 is 2.8 times that of the previous fiscal year. *Miyoshi Oil & Fat ＜4404＞ 1412+157 1st quarter operating profit was 1,233 billion yen. A deficit of 123 million yen in the same period last year turned into a surplus. *Daicel ＜4202＞ announced changes to its 1558.5 +90 shareholder return policy and cancellation of company shares. *Data HR ＜3628＞ Earnings Forecast for the Fiscal Year Ending 630-10624-6
High stop/low stop-down stocks backstage
■Stop High ＜1436＞GreenEnergy & Company ＜3271＞The Global Company ＜3750＞Cytri Cell Research Institute ＜4922＞KOSE ＜6026＞GMO TECH ＜6208＞Ishikawa Seisakusho ＜6840＞AKIBA Holdings ＜7012＞Kawasaki Heavy Industries ＜7689＞Copa Corporation＜8012＞Nagase Sangyo ＜9235＞ Internet advertising company that sells ■Stop cheap ＜7069＞Cyber Buzz※temporarily Stop high/low (sign
Featured Stock Digest (previous market): Omron, ROHM, ORIX, etc.
Toyota's own ＜7203＞: 3580 yen (+1 yen) is a development where the price returns after being sold ahead of time. Financial results for the fiscal year ending 24/3 were announced during trading hours the day before, and the implementation of a stock buyback with an upper limit of 1 trillion yen was well received and there was also a movement to temporarily switch back. Today, we are once again returning values from developments where financial results are viewed as sales material. Operating profit for the fiscal year ending 25/3 is 4.3 trillion yen, which is expected to decrease 19.7% from the previous fiscal year, which is about 1 trillion yen below market consensus.
Cyber Buzz --- stop low sales signs, operating profit and loss forecast for the fiscal year ending 24/9 revised downward, falling into the red due to debt loss provisions
There is a sign that bargain sales will stop. The operating profit and loss forecast for the fiscal year ending 24/9 has been revised downward from the previous surplus of 470 million yen to a deficit of 1,745 billion yen (surplus of 391 million yen in the previous fiscal year). Sales were revised upward from 6.720 billion yen to 7.420 billion yen (same 5.757 billion yen) in response to strong sales of influencer services and internet advertisement sales, but since loan provision amounts of 2,215 billion yen due to the risk of inability or delays in collection of claims were recorded as SG&A expenses, there was a deficit
US long-term interest rates, which are weak and strong, are becoming heavy
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to develop softly. In the US stock market yesterday 8th, the Dow average rose 172.13 dollars (+ 0.44%) to 39,056.39 dollars and continued to rise for 6 days. While buying in anticipation of a good economy supported stock prices, long-term US interest rates rose in response to statements from US financial officials, etc., and weighed on stock prices for high-tech stocks. Today's emerging markets are likely to be dominated by sales. The Dow average continued to rise for 6 days in overseas markets yesterday, but US long-term interest rates
GMOTECH, GMOTECH, etc.
＜3628＞Data HR revised downward, sales forecast for the current fiscal year 4.90 billion yen ← 6.300 billion yen ＜4579＞LaQuoria Drug Discovery Phase I Clinical Trials Begin in Australia ＜4582＞Clinical Trials Targeting Cytomegalovirus Infection After Hematopoietic Stem Cell Transplantation in Phase IIa Clinical Trial (ATHENA Test) with the Synbio Pharmaceutical Injection Brincidofovir Begin Clinical Trials Targeting Cytomegalovirus Infection After Hematopoietic Stem Cell Transplantation ＜6026＞GMOTECH Upward Revised for the Current Fiscal Year ＜6026＞GMOTECH Upward Revised for the Current Fiscal Year Forecast 1,040 million yen ←
Analysis
Price Target
No Data
